Status:
COMPLETED
The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
Lead Sponsor:
Odense University Hospital
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Patients suffering from diabetes through many years have a risk of developing late diabetic complications including changes in eyes, kidney, vessels and nerves. Late complications can be postponed or ...
Eligibility Criteria
Inclusion
- Patients with type 1 diabetes mellitus treated with insulin 4 times daily.
- Age: 18-60 years
- Fertile women use adequate contraception, e.g. contraceptive pills
- C-peptide \<300 pmol/L
- BMI \>/= 25
- HbA1c \>/=8%
Exclusion
- Pregnant and patients planning to become pregnant during the investigation period
- Reduced eyesight
- Known kidney disease, s-creatinin \>100
- Liver disease, Alat \> 50
- Neuropathic patients diagnosed by clinical examination
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00145379
Start Date
March 1 2003
End Date
June 1 2006
Last Update
May 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Research Center
Odense, Funen, Denmark, 5000